These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7898087)

  • 1. New Clinical Aspects in the Therapy of Hypertension with ACE Inhibitors and Calcium Antagonists. Proceedings of a workshop. Bad Reichenhall, Germany, February 19-20, 1993.
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-112. PubMed ID: 7898087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes mellitus and hypertension: calcium antagonists or ACE inhibitors?].
    Jungmann E
    Dtsch Med Wochenschr; 1991 May; 116(22):859-62. PubMed ID: 2036945
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage.
    Raij L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():23-7. PubMed ID: 8643203
    [No Abstract]   [Full Text] [Related]  

  • 4. Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare?
    Maschio G
    Nephron; 1994; 67(3):257-62. PubMed ID: 7936013
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors or calcium antagonists for treating hypertension?
    Ferner RE
    J Hum Hypertens; 1997 Aug; 11(8):469-70. PubMed ID: 9322825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials].
    Schillaci G; Vaudo G
    Ital Heart J Suppl; 2001 Jul; 2(7):799-802. PubMed ID: 11508301
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors and calcium antagonists in the progression of renal insufficiency.
    Zucchelli P; Gaggi R; Zuccalà A
    Contrib Nephrol; 1992; 98():116-24. PubMed ID: 1493723
    [No Abstract]   [Full Text] [Related]  

  • 9. Progression of renal diseases--angiotensin-converting enzyme inhibitors versus calcium antagonists.
    S Afr Med J; 1996 Apr; 86 Suppl 2():C114. PubMed ID: 8711574
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations in microalbuminuria in essential hypertension treated with ACE inhibitors, calcium antagonists and their association].
    Abate D; Cafà R; Castellino AR; Maligno C; Sorrusca F; Abate FC
    Minerva Cardioangiol; 1995; 43(7-8):303-7. PubMed ID: 8538903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview.
    Gavras H
    Drugs; 1990; 39 Suppl 2():73-5. PubMed ID: 2140550
    [No Abstract]   [Full Text] [Related]  

  • 12. CCB/ACE inhibitor dual therapy for hypertension lowers cardiovascular risk.
    Mitka M
    JAMA; 2008 May; 299(19):2263-4. PubMed ID: 18492960
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease.
    Ritz E; Orth SR; Strzelczyk P
    J Hypertens Suppl; 1997 Mar; 15(2):S21-6. PubMed ID: 9218194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do calcium antagonists should be still an initial therapy in hypertension?].
    Głuszek J; Pawlaczyk-Gabriel K
    Pol Arch Med Wewn; 2003 Feb; 109(2):189-94. PubMed ID: 12879783
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers or angiotensin-converting enzyme inhibitors for de novo hypertension after liver transplant: and the winner is …?
    Carbone M; Sagar V; Ferguson J; Neuberger J
    Transplantation; 2012 Jan; 93(2):e2-4. PubMed ID: 22234315
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of posttranplant hypertension: ACE is trumped?
    Dudley CR
    Transplantation; 2001 Dec; 72(11):1728-9. PubMed ID: 11740380
    [No Abstract]   [Full Text] [Related]  

  • 20. New guidelines on hypertension.
    Cruickshank JM
    Lancet; 2006 Aug; 368(9536):641. PubMed ID: 16920457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.